Cargando…

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is the most lethal gynecological cancer, despite advances in patient stratification and treatment. Despite initial response to first-line treatment, most patients suffer a relapse and die from treatment-resistant disease. We identified three predictive protein biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arentz, Georgia, Mittal, Parul, Klingler-Hoffmann, Manuela, Condina, Mark R., Ricciardelli, Carmela, Lokman, Noor A., Kaur, Gurjeet, Oehler, Martin K., Hoffmann, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093294/ https://www.ncbi.nlm.nih.gov/pubmed/37046833 http://dx.doi.org/10.3390/cancers15072172

Ejemplares similares

MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia
por: Zhang, Chao, et al.
Publicado: (2016)

Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021)

Cancer Tissue Classification Using Supervised Machine Learning Applied to MALDI Mass Spectrometry Imaging
por: Mittal, Paul, et al.
Publicado: (2021)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
por: Acland, Mitchell, et al.
Publicado: (2020)

A Protocol for the Acquisition of Comprehensive Proteomics Data from Single Cases Using Formalin-Fixed Paraffin Embedded Sections
por: Acland, Mitchell, et al.
Publicado: (2022)

Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations
por: Acland, Mitchell, et al.
Publicado: (2022)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

In-House Packed Porous Graphitic Carbon Columns for Liquid Chromatography-Mass Spectrometry Analysis of N-Glycans
por: Young, Clifford, et al.
Publicado: (2021)

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels
por: Khan, Sidra, et al.
Publicado: (2023)

Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis
por: Lokman, Noor A., et al.
Publicado: (2012)

S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer
por: Noye, Tannith M., et al.
Publicado: (2018)

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
por: Lokman, Noor A., et al.
Publicado: (2013)

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer
por: Weiland, Florian, et al.
Publicado: (2020)

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer
por: Lee, Eunice, et al.
Publicado: (2020)

Increased Phospho-Keratin 8 Isoforms in Colorectal Tumors Associated with EGFR Pathway Activation and Reduced Apoptosis
por: Arentz, Georgia, et al.
Publicado: (2012)

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways
por: Price, Zoe K., et al.
Publicado: (2022)

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome
por: Wang, Wanqi, et al.
Publicado: (2021)

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance
por: Price, Zoe K., et al.
Publicado: (2018)

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer
por: Price, Zoe K., et al.
Publicado: (2023)

Protein Profiling in Human Papillomavirus-Associated Cervical Carcinogenesis: Cornulin as a Biomarker for Disease Progression
por: Kumarasamy, Gaayathri, et al.
Publicado: (2023)

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype
por: Cheung, Janelle, et al.
Publicado: (2020)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Mass Spectrometry Imaging as a Potential Tool to Investigate Human Osteoarthritis at the Tissue Level
por: Lee, Yea-Rin, et al.
Publicado: (2020)

Spinal anesthesia in a patient with grade IV Bell’s palsy for caesarean section
por: Jindal, Parul, et al.
Publicado: (2021)

Mass spectrometry imaging spatially identifies complex-type N-glycans as putative cartilage degradation markers in human knee osteoarthritis tissue
por: Lee, Yea-Rin, et al.
Publicado: (2022)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
por: Ween, Miranda P., et al.
Publicado: (2012)

Optical Fibre-Enabled Photoswitching for Localised Activation of an Anti-Cancer Therapeutic Drug
por: Palasis, Kathryn A., et al.
Publicado: (2021)

Balancing sufficiency and impact in reporting standards for mass spectrometry imaging experiments
por: Gustafsson, Ove J R, et al.
Publicado: (2018)

Targeting CDK9 for treatment of colorectal cancer
por: Rahaman, Muhammed H., et al.
Publicado: (2019)

Ultrahigh Resolution Lipid Mass Spectrometry Imaging of High-Grade Serous Ovarian Cancer Mouse Models
por: Ma, Xin, et al.
Publicado: (2023)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
por: Weiland, Florian, et al.
Publicado: (2012)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

Raw N-glycan mass spectrometry imaging data on formalin-fixed mouse kidney
por: Gustafsson, Ove J.R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oo9nmt9kelldd93kfffo7pidqn